Copyright © 2008 The American Society of Human Genetics. All rights reserved.
The American Journal of Human Genetics, Volume 82, Issue 2, 477-488, 17 January 2008
doi:10.1016/j.ajhg.2007.12.009
Article
Christian R. Marshall1, Abdul Noor2, John B. Vincent2, Anath C. Lionel1, Lars Feuk1, Jennifer Skaug1, Mary Shago3, Rainald Moessner1, Dalila Pinto1, Yan Ren1, Bhooma Thiruvahindrapduram1, Andreas Fiebig6, Stefan Schreiber6, Jan Friedman7, Cees E.J. Ketelaars8, Yvonne J. Vos8, Can Ficicioglu9, Susan Kirkpatrick10, Rob Nicolson11, Leon Sloman2, Anne Summers12, Clare A. Gibbons12, Ahmad Teebi4, David Chitayat4, Rosanna Weksberg4, Ann Thompson13, Cathy Vardy14, Vicki Crosbie14, Sandra Luscombe14, Rebecca Baatjes1, Lonnie Zwaigenbaum15, Wendy Roberts5, 16, Bridget Fernandez14, Peter Szatmari13 and Stephen W. Scherer1,
, 
1 The Centre for Applied Genomics and Program in Genetics and Genomic Biology, The Hospital for Sick Children, and Department of Molecular and Medical Genetics, University of Toronto, Toronto, Ontario M5G 1L7, Canada
2 Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Ontario M5T 1R8, Canada
3 Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
4 Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
5 Autism Research Unit, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
6 Institute for Clinical Molecular Biology, Christian-Albrechts-University, 24105 Keil, Germany
7 Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada
8 Department of Child Psychiatry, University Medical Center Groningen, 9700 RB Groningen, The Netherlands
9 Division of Metabolism, Children's Hospital of Philadelphia, Philadelphia, PA 19104-4318, USA
10 Department of Medical Genetics, University of Wisconsin, Madison, WI 53706-1580, USA
11 Department of Psychiatry, University of Western Ontario, London, Ontario N6A 4G5, Canada
12 Department of Genetics, North York General Hospital, Toronto, Ontario M2K 1E1, Canada
13 Offord Centre for Child Studies, Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario L8P 3B6, Canada
14 Disciplines of Genetics and Medicine, Memorial University of Newfoundland, St. John's, Newfoundland A1B 3V6, Canada
15 Department of Pediatrics, University of Alberta, Edmonton, Alberta T6G 2J3, Canada
16 Bloorview Kids Rehab, University of Toronto, Toronto, Ontario M4G 1R8, Canada
Corresponding authorAbstract
Structural variation (copy number variation [CNV] including deletion and duplication, translocation, inversion) of chromosomes has been identified in some individuals with autism spectrum disorder (ASD), but the full etiologic role is unknown. We performed genome-wide assessment for structural abnormalities in 427 unrelated ASD cases via single-nucleotide polymorphism microarrays and karyotyping. With microarrays, we discovered 277 unbalanced CNVs in 44% of ASD families not present in 500 controls (and re-examined in another 1152 controls). Karyotyping detected additional balanced changes. Although most variants were inherited, we found a total of 27 cases with de novo alterations, and in three (11%) of these individuals, two or more new variants were observed. De novo CNVs were found in ∼7% and ∼2% of idiopathic families having one child, or two or more ASD siblings, respectively. We also detected 13 loci with recurrent/overlapping CNV in unrelated cases, and at these sites, deletions and duplications affecting the same gene(s) in different individuals and sometimes in asymptomatic carriers were also found. Notwithstanding complexities, our results further implicate the SHANK3-NLGN4-NRXN1 postsynaptic density genes and also identify novel loci at DPP6-DPP10-PCDH9 (synapse complex), ANKRD11, DPYD, PTCHD1, 15q24, among others, for a role in ASD susceptibility. Our most compelling result discovered CNV at 16p11.2 (p = 0.002) (with characteristics of a genomic disorder) at ∼1% frequency. Some of the ASD regions were also common to mental retardation loci. Structural variants were found in sufficiently high frequency influencing ASD to suggest that cytogenetic and microarray analyses be considered in routine clinical workup.
| Contribution of SHANK3 Mutations to Autism Spectrum Disorder The American Journal of Human Genetics, Volume 81, Issue 6, 1 December 2007, Pages 1289-1297 Rainald Moessner, Christian R. Marshall, James S. Sutcliffe, Jennifer Skaug, Dalila Pinto, John Vincent, Lonnie Zwaigenbaum, Bridget Fernandez, Wendy Roberts, Peter Szatmari and Stephen W. Scherer Abstract Mutations in SHANK3, which encodes a synaptic scaffolding protein, have been described in subjects with an autism spectrum disorder (ASD). To assess the quantitative contribution of SHANK3 to the pathogenesis of autism, we determined the frequency of DNA sequence and copy-number variants in this gene in 400 ASD-affected subjects ascertained in Canada. One de novo mutation and two gene deletions were discovered, indicating a contribution of 0.75% in this cohort. One additional SHANK3 deletion was characterized in two ASD-affected siblings from another collection, which brings the total number of published mutations in unrelated ASD-affected families to seven. The combined data provide support that haploinsufficiency of SHANK3 can cause a monogenic form of autism in sufficient frequency to warrant consideration in clinical diagnostic testing. Abstract | | |
| Oligonucleotide Microarray Analysis of Genomic Imbalance in Children with Mental Retardation The American Journal of Human Genetics, Volume 79, Issue 3, 1 September 2006, Pages 500-513 J.M. Friedman, Ágnes Baross, Allen D. Delaney, Adrian Ally, Laura Arbour, Jennifer Asano, Dione K. Bailey, Sarah Barber, Patricia Birch, Mabel Brown-John, Manqiu Cao, Susanna Chan, David L. Charest, Noushin Farnoud, Nicole Fernandes, Stephane Flibotte, Anne Go, William T. Gibson, Robert A. Holt, Steven J.M. Jones, Giulia C. Kennedy, Martin Krzywinski, Sylvie Langlois, Haiyan I. Li, Barbara C. McGillivray, Tarun Nayar, Trevor J. Pugh, Evica Rajcan-Separovic, Jacqueline E. Schein, Angelique Schnerch, Asim Siddiqui, Margot I. Van Allen, Gary Wilson, Siu-Li Yong, Farah Zahir, Patrice Eydoux and Marco A. Marra Abstract The cause of mental retardation in one-third to one-half of all affected individuals is unknown. Microscopically detectable chromosomal abnormalities are the most frequently recognized cause, but gain or loss of chromosomal segments that are too small to be seen by conventional cytogenetic analysis has been found to be another important cause. Array-based methods offer a practical means of performing a high-resolution survey of the entire genome for submicroscopic copy-number variants. We studied 100 children with idiopathic mental retardation and normal results of standard chromosomal analysis, by use of whole-genome sampling analysis with Affymetrix GeneChip Human Mapping 100K arrays. We found de novo deletions as small as 178 kb in eight cases, de novo duplications as small as 1.1 Mb in two cases, and unsuspected mosaic trisomy 9 in another case. This technology can detect at least twice as many potentially pathogenic de novo copy-number variants as conventional cytogenetic analysis can in people with mental retardation. Abstract | | |